samedan logo
 
 
spacer
home > white papers > Pandemic respiratory vaccine clinical trials: a departure from business as usual - ICON plc
WHITE PAPERS
logo_ICON_plco.jpg

ICON plc

phone +353 1 291 2883
email info-clinical@iconplc.com
web http://www.iconplc.com
email ICON plc, Headquarters, South County Business Park, Leopardstown, Dublin 18, Ireland

Pandemic respiratory vaccine clinical trials: a departure from business as usual

Around the world, the “V” words are on everyone’s lips: Virus and Vaccines. In response to the urgent need for a vaccine for COVID-19, researchers are, at time of publication, running 500+ clinical trials (and counting) on a number of antivirals, antibodies and vaccines. Promising possibilities range from novel new drugs/vaccines, repurposing treatments currently indicated for HIV, Ebola and malaria, to monoclonal antibodies and immune serum.
Pandemic respiratory vaccine clinical trials: a departure from business as usual
spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

Avantor® Opens Single-Use Logistics Hub to Strengthen Global Biopharma Supply Chain

New facility in Westminster, Mass., provides reliable and comprehensive support for single-use business.
More info >>


White Papers


©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement